NantOmics Receives Certification from the Centers for Medicare and Medicaid Services and Accreditation from the College of American Pathologists

The CLIA certification and CAP accreditation ensures the highest quality test results from the NantOmics lab to help improve cancer outcomes and will support the Cancer Breakthroughs 2020 mission in its war on cancer

CULVER CITY, Calif. – April 19, 2016 – NantOmics, LLC, the leader in molecular diagnostics and member of the NantWorks ecosystem of families, today announced that its laboratories have been certified by the U.S. Department of Health and Human Services' Centers for Medicare & Medicaid Services under the Clinical Laboratory Improvement Acts (CLIA) of 1988, and has been accredited by the College of American Pathologists (CAP). As the nation’s first and only CLIA-certified, CAP-accredited laboratories to perform whole genome (DNA) sequencing, whole transcriptome (RNA) sequencing, and quantitative proteomics—all in one comprehensive test—today’s announcement exemplifies the highest quality standard delivered by NantOmics to ensure accuracy, reliability, and timeliness of patient test results.